Miguel Bronchud, Co-Founder and Advisory Board at Regenerative Medicine Solutions, shared a post on LinkedIn:
“G7- June 2026: cancer as a global strategic priority?
At the initiative of President Emmanuel Macron and under the French presidency of the G7, leaders officially affirmed their shared commitment to accelerate the fight against cancer, with three priorities highlighted:
Pediatric cancers: promoting data sharing, because no country alone has the volume of data necessary to make sufficient progress.
Poor-prognosis cancers (lung, liver, and pancreatic cancers): establishing common definitions, strengthening screening efforts, improving stage 1 diagnosis, and reducing lung cancer mortality over the next ten years.
Universal access to quality care in both high-income and developing countries, recognizing that no effective fight against cancer can ignore equity.
Congratulations to everyone whose efforts and mobilization made it possible to achieve this historic declaration for a disease that claims 10 million lives worldwide every year.
The World Health Organization (WHO), the WHO Regional Office for Europe, the European Union, governments, and hopefully institutions such as the French National Cancer Institute will benefit from these important commitments for the benefit of patients worldwide.”
Other articles about Pancreatic Cancer on OncoDaily.